Skip to main navigation Skip to search Skip to main content

Atherosclerosis is associated with plasma Aβ levels in non-hypertension patients

  • Chen Chen
  • , Wang Anqi
  • , Gao Ling
  • , Wei Shan
  • , Dang Liangjun
  • , Shang Suhang
  • , Huo Kang
  • , Gao Fan
  • , Wang Jingyi
  • , Qu Qiumin
  • , Wang Jin
  • The First Affiliated Hospital of Xi’an Jiaotong University
  • Huyi Hospital of Traditional Chinese Medicine

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Background: Growing evidence indicated that to develop of atherosclerosis observed more often by people with Alzheimer’s disease (AD), but the underlying mechanism is not fully clarified. Considering that amyloid-β (Aβ) deposition in the brain is the key pathophysiology of AD and plasma Aβ is closely relate to Aβ deposition in the brain, in the present study, we investigated the relationships between atherosclerosis and plasma Aβ levels. Methods: This was a population based cross-sectional study. Patients with high risk of atherosclerosis from Qubao Village, Xi’an were underwent carotid ultrasound for assessment of atherosclerosis. Venous blood was collected on empty stomach in the morning and plasma Aβ1−40 and Aβ1−42 levels were measured using ELISA. Multivariate logistic regression analysis was performed to investigate the relationships between carotid atherosclerosis (CAS) and plasma Aβ levels. Results: Among 344 patients with high risk of atherosclerosis, 251(73.0%) had CAS. In the univariate analysis, the plasma Aβ levels had no significant differences between CAS group and non-CAS group (Aβ1−40: 53.07 ± 9.24 pg/ml vs. 51.67 ± 9.11pg/ml, p = 0.211; Aβ1−42: 40.10 ± 5.57 pg/ml vs. 40.70 pg/ml ± 6.37pg/ml, p = 0.285). Multivariate logistic analysis showed that plasma Aβ levels were not associated with CAS (Aβ1−40: OR = 1.019, 95%CI: 0.985–1.054, p = 0.270;Aβ1−42: OR = 1.028, 95%CI: 0.980–1.079, p = 0.256) in the total study population. After stratified by hypertension, CAS was associated with plasma Aβ1−40 positively (OR = 1.063, 95%CI: 1.007–1.122, p = 0.028) in the non-hypertension group, but not in hypertensive group. When the plasma Aβ concentrations were classified into four groups according to its quartile, the highest level of plasma Aβ1−40 group was associated with CAS significantly (OR = 4.465, 95%CI: 1.024–19.474, p = 0.046). Conclusion: Among patients with high risk of atherosclerosis, CAS was associated with higher plasma Aβ1−40 level in non-hypertension group, but not in hypertension group. These indicated that atherosclerosis is associated with plasma Aβ level, but the relationship may be confounded by hypertension.

Original languageEnglish
Article number218
JournalBMC Neurology
Volume24
Issue number1
DOIs
StatePublished - Dec 2024
Externally publishedYes

Keywords

  • Alzheimer’s disease
  • Atherosclerosis
  • Plasma Aβ
  • Risk factors

Fingerprint

Dive into the research topics of 'Atherosclerosis is associated with plasma Aβ levels in non-hypertension patients'. Together they form a unique fingerprint.

Cite this